27 February 2008
Race and ethnicity coding agreement between hospitals and between hospital and death data
Kevin Fiscella, Sean MeldrumMed Sci Monit 2008; 14(3): SR9-13 :: ID: 836567
Abstract
Background
Little is known regarding the reliability of hospital coding for race and ethnicity particularly for Hispanics, Asians, and American Indians. We assessed these questions using hospital and mortality data from a large, diverse state.
Material and Method
We used California hospital discharge data 1998--2000 and linked death data. We assessed crude agreement and kappas for race and ethnicity coding between admissions to different hospitals and between hospital admissions and death data.
Results
Overall kappas for race and ethnicity were higher between hospital and death data than between different hospitals. Kappas between hospital admission and death certificate data differed by race and ethnicity. Reasonable kappas were observed for Blacks (0.92), Asians and Pacific Islanders (0.88), Hispanics (0.77), and Whites (0.76), but not for American Indians (0.27) or others (<0.01). Crude agreement for race and ethnicity varied for Asians and Hispanics based on country of origin. It was highest for persons born in China (93%) and Southeast Asian (93%) and Mexico (82%) and lowest for persons born in India (38%) and for "Other Spanish/Hispanics" born in (42%) and outside the US (46%).
Conclusions
Race and ethnicity coding agreement between hospitals and between hospitals and death certificate is generally good for most major and ethnic groups and subgroups with the notable exception of American Indians, persons of other races, and selected Asians and Hispanics born in certain countries.
Keywords: Medical Records - statistics & numerical data, Mortality - ethnology, Forms and Records Control - methods, Death Certificates, Ethnic Groups - statistics & numerical data, Cross-Sectional Studies, Continental Population Groups - statistics & numerical data
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952